Robust In Vitro Models for Studying Parkinson's Disease? LUHMES Cells and SH-SH5Y Cells. [PDF]
Keighron CN, Avazzedeh S, Quinlan LR.
europepmc +1 more source
The Neuroprotective Effects of the Crinoid Natural Compound Rhodoptilometrin in Parkinson's Disease Experimental Models: Implications for ER Stress and Autophagy Modulation. [PDF]
Wen ZH +7 more
europepmc +1 more source
Liquiritigenin-Rich Hydroalcoholic Extract of Brazilian Red Propolis Reduces Dyskinesia Induced by 3,4- Dihydroxyphenylalanine in Hemiparkinsonian Rats. [PDF]
da Silva Barroso S +9 more
europepmc +1 more source
Golexanolone affords sustained microglia and astrocytes activation improvement in a rat model of Parkinson's disease. [PDF]
Mincheva G +7 more
europepmc +1 more source
Striatal Serotonin 4 Receptor is Increased in Experimental Parkinsonism and Dyskinesia. [PDF]
Cirillo R +11 more
europepmc +1 more source
MRI-guided focused ultrasound for treating Parkinson's disease with human mesenchymal stem cells. [PDF]
Wu SK, Tsai CL, Mir A, Hynynen K.
europepmc +1 more source
Hyperglycemia Aggravates 6-Hydroxydopamine-Induced Neuronal Ferroptosis via SLC7A11-Dependent Pathway in Diabetic PD Rat Model. [PDF]
Zhao Y +5 more
europepmc +1 more source
Assessment of complementary white matter microstructural changes and grey matter atrophy in the 6-OHDA-induced model of Parkinson's disease. [PDF]
Bergamino M +6 more
europepmc +1 more source
Brainstem Neuroadaptations in Rodent Models of Parkinson's Disease. [PDF]
Al Tannir R +4 more
europepmc +1 more source

